Nature Reviews Nephrology

Article	Citations
A UMOD variant with intermediate effects	1050
Mentorship in the lives of scholars	982
Kidney health within the broader non-communicable disease agenda	595
Inhibitory effects of oestradiol on ferroptosis may underlie sex differences in AKI	564
The changing landscape of kidney health and disease in Africa	549
The GLP-1 receptor agonist revolution comes to nephrology	479
Disaster preparedness for patients with kidney disease	450
Treatment of chronic kidney disease in older populations	400
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	375
Engineered CAR macrophages target kidney inflammation	342
CD93 and endothelial cells as therapeutic targets in podocytopathies	300
Making advance care planning easier for adults with kidney disease and their clinicians	286
Role of the gut microbiota in the pathogenesis of IgA nephropathy	267
Urine as a source of biomarkers and biological knowledge in chronic kidney disease	264
Uropathogen and host responses in pyelonephritis	251
Author Correction: Salt and chronic kidney disease	239
Designing acute kidney injury clinical trials	228
Vaccination in patients with kidney failure: lessons from COVID-19	212
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease	211
A single-cell atlas of DKD treatment responses	210
Genetic determinants of urine and plasma metabolite levels	194
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	188
Beyond state borders: transforming dialysis care for undocumented immigrants	174
The continued odyssey to unravel the secrets of kidney inflammation	170
Consideration of sex differences is necessary to achieve health equity	163

Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	162
Roles of sensory receptors in non-sensory organs: the kidney and beyond	144
Complosome — the intracellular complement system	141
Strategic rebalancing of kidney-related investments is key to implementing the WHO kidney health resolution	140
Phosphate sensing via PTC glycolysis	129
Reducing preventable acute kidney injury in a hospital setting	126
Mutational signatures of ccRCC vary between geographical regions	125
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	113
Informing clinical decision making during a pandemic — a call for better preparedness	112
The effects of sex hormone therapy on kidney function	111
Clonal haematopoiesis and AKI	104
20 years of Nature Reviews Nephrology	103
Aquaporin water channels: roles beyond renal water handling	98
The impact of social determinants of health on acute kidney injury	98
The roles of hyaluronan in kidney development, physiology and disease	98
Increasing diversity and inclusion in nephrology clinical trials	95
Menopause and chronic kidney disease	92
Design of a renal-sparing antifungal	90
Heat and health inequity: acting on determinants of health to promote heat justice	89
Tertiary lymphoid organs contribute to kidney allograft rejection	89
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	89
Environmental stewardship and health systems: Indigenous-centred reflections	87
Salt substitution: opportunities and challenges for nephrology	87
Benefits of actin cytoskeleton stabilization	83
Identification of erythropoietin-producing cells	83
From fat to filter: the effect of adipose tissue-derived signals on kidney function	82
Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure	79
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	78
Treatment of SLE with anti-CD19 CAR-T cells	76
Long-term health outcomes associated with hydration status	74
Neutrophils and NETs in kidney disease	74
Pathological mechanisms of kidney disease in ageing	73
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	71
The role of complement in kidney disease	71
A label-free optical analysis for molecular nephrology	70
A golden year of innovative kidney disease therapeutics	69
Reaping the rewards of mechanistic discovery in glomerular disease	66
MSC therapy for diabetic kidney disease and nephrotic syndrome	64
The evolving landscape of immune-mediated glomerular diseases	63
A pathway of osmotic stress-induced necroptosis	63
Combination therapy for kidney disease in people with diabetes mellitus	60
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	59
Network medicine: an approach to complex kidney disease phenotypes	58
Ketogenic diet benefits in critically ill patients with sepsis	58
Atmospheric stressors and kidney diseases	58
Consequences of famine and malnourishment on kidney health	57
Quality-oriented diet therapy for chronic kidney disease	57
Long COVID and the kidney	57
The cilia mechanosensation debate gets (bio)physical	52
PDGFRβ CAR T cells improve fibrosis in kidney disease models	51

Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors	49
Role of the cGAS–STING pathway in systemic and organ-specific diseases	49
Consequence of microvascular inflammation in transplantation	48
GalNAc-T14-associated defects in B cell homing in IgA nephropathy	48
Community power building to reduce inequities in access to health care	47
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	46
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia	45
Dietary protection of proximal tubules in diabetes	44
Mechanism of B cell survival in lupus nephritis	44
Steps forward in the treatment of IgA nephropathy	43
Gene therapy in a model of nephrotic syndrome	43
The kidney is a novel target of metformin	43
Metabolic alterations in hereditary and sporadic renal cell carcinoma	43
Mannose as a driver of γδ T cell kidney infiltration	43
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	42
A guide to gene–disease relationships in nephrology	42
Chronic cardiovascular–kidney disorder: a new conceptual framework	42
Wearable biosensor can detect impaired kidney drug clearance	41
Targeting IL-1Ra to attenuate fungal infection	39
Generation of self-assembling kidney progenitor assembloids	39
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	38
Born too soon: lifelong kidney risks and the importance of early intervention	37
The genetics of hypertension	37
Epithelial cell states associated with kidney and allograft injury	36
Multifaceted innovations needed to advance transplant nephrology	36
Anti-neutrophil cytoplasmic antibody-associated vasculitis: biological insights and biomarker-guided disease management	35
Role of necroptosis in kidney health and disease	34
Derivation of collecting duct organoids	34
IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxis	34
Fasting induces structural and functional changes in the peritoneal membrane	34
Insights into the impact of pregnancy on kidney disease	33
Strategies to achieve gender equity in nephrology	33
The increasing burden of mild and moderate anaemia in CKD	32
Author Correction: Therapeutic advances in COVID-19	29
The impact of intrauterine growth restriction and prematurity on nephron endowment	29
From big data to smart decisions: artificial intelligence in kidney risk assessment	29
Green nephrology: from evidence to action	29
Leveraging data as a patient–scientist: frustrations and opportunities	29
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	28
Renal nerves in physiology, pathophysiology and interoception	28
Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effects	28
Acute kidney injury in patients with burns	27
A guide to uraemic toxicity	27
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	27
The immunology of sepsis: translating new insights into clinical practice	26
Fibroblast activation and heterogeneity in fibrotic disease	26
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	25
Digital determinants of health: opportunities and risks amidst health inequities	24
Switching off SOX9 for epithelial recovery after AKI	24
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	23
Collagen formation, function and role in kidney disease	23
When access outpaces ethics: reflections on dialysis expansion and health system integrity	22
CD38 — a new target in renal immune disease	22
Hope for resistant hypertension through BrigHTN and PRECISION	21
The impact of population ageing on the burden of chronic kidney disease	21
Impact of persistent conflict and destabilizing events on dialysis care	21
Improving the quality of pharmacoepidemiological studies using the target trial emulation framework	20
Crosstalk between glomeruli and tubules	20
Nephrology and women’s health post-Roe v. Wade: we must do better	20
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup	20
Application of spatial-omics to the classification of kidney biopsy samples in transplantation	19
Bridging the gap of referral to nephrology care	19
A year of disruption and progress in kidney health policy	18
Indigenous kidney health outcomes will not improve without multilevel interventions	18
A novel gene therapy approach for nephropathic cystinosis	18
Kidney transplants: from antigen recognition to targeted therapy	18
Deep learning applications in digital pathology	17
Pathogenic cellular and molecular mediators in lupus nephritis	16
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis	16
The endothelium response to kidney injury	16
Podocyte-targeted therapies — progress and future directions	15
Cellular senescence: the good, the bad and the unknown	15
Increased PD1 signalling in kidney ageing	14
Use of kidneys from SARS-CoV-2 infected donors	14
P3H2 in glomerular basement membrane regulation	14
Trained immunity: from kidney failure to organ transplantation	13
Publisher Correction: Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	13
Lived experience and empathy: lessons learned as a nephrologist with kidney disease	13
New and emerging therapies for diabetic kidney disease	12
Insights into glomerular function and disease pathogenesis	12

New evidence of the impact of mitochondria on kidney health and disease	12
Gasdermins and pyroptosis in the kidney	11
Vascular damage in systemic lupus erythematosus	11
TRPM channels in health and disease	11
Progress towards solving the donor organ shortage	11
Thiazides in kidney transplant recipients: skin in the game	10
Advances and challenges in kidney fibrosis therapeutics	10
Author Correction: Beyond state borders: transforming dialysis care for undocumented immigrants	10
Incorporating dementia screening in the care of patients with kidney disease	10
Pharmacogenomics in the clinic	10
Important roles of mechanical force and hydraulic pressure in kidney function	10
The genetics and pathogenesis of CAKUT	9
Advances in risk prediction and treatment strategies for CKM syndrome	9
Kidney health outcomes of hypertensive disorders of pregnancy	9
Diuretics in patients with chronic kidney disease	9
Cystatin C and the misdiagnosis of CKD in older adults	9
Cell and gene therapy for kidney disease	9
Inflammation and gut dysbiosis as drivers of CKD–MBD	8
Anti-nephrin autoantibodies: a paradigm shift in podocytopathies	8
Advancing gender equity to improve kidney care for women: a patient perspective	8
ECM remodelling by ADAMTS12 in fibrosis	8
Clonal haematopoiesis, ageing and kidney disease	8
Disasters and kidney care: pitfalls and solutions	7
Advances in CRISPR therapeutics	7
Synchronization in the renal microcirculation	7
Patient involvement in nephrology research	7
Youth-onset type 2 diabetes mellitus: an urgent challenge	7
The role of lysosomes in metabolic and autoimmune diseases	7
Remodelling by macula densa cells	7
Electronic patient-reported outcomes in chronic kidney disease	7
Progress in xenotransplantation: overcoming immune barriers	7
Chronic kidney disease and the global public health agenda: an international consensus	7
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential	7
Long-term lessons from EMPA-KIDNEY	6
Including sexual orientation and gender identity data to advance nephrology care	6
Graph neural networks for computational nephrology	6
Intersectionality as a lens for achieving kidney health justice	6
A guide to studying 3D genome structure and dynamics in the kidney	6
Renoprotective effects of sparsentan: clinical trial evidence in IgA nephropathy and FSGS	6
The slit diaphragm has a conserved fishnet architecture	6
Diagnosis of cardiovascular disease in patients with chronic kidney disease	6
Avenciguat reduces albuminuria in patients with chronic kidney disease	6
The pathogenesis of pre-eclampsia in kidney donors	6
The intelligent podocyte: sensing and responding to a complex microenvironment	6
‘Missing’ disease-causing variants in Alport syndrome	6
Drug repurposing for glomerular diseases: an underutilized resource	6
Paths to organ damage and risk factors in AKI	5
Inequities in kidney health and kidney care	5
Removal of small, asymptomatic kidney stones	5
Iron deficiency of kidney macrophages in CKD	5
The kidney stroma in development and disease	5
Targeting iron uptake to correct T cell dysfunction	5
The catastrophic costs of chronic kidney disease	5
Amino acid metabolism in kidney health and disease	5
UTX regulates accumulation of lipids via kidney serine	5
Sexual orientation and gender identity in organ and tissue donation and transplantation	5
Interactive exploration of multimodal spatial data with FUSION	5
New insights into kidney crosstalk with distant organs	5
Selective autophagy in kidney health and disease	5
Post-translational modifications in kidney diseases and associated cardiovascular risk	5
A polygenic score predicts CKD across ancestries	5
Improving nephrology care for people with cognitive impairments and their caregivers	5
Sex differences in kidney metabolism and DKD	5
NCKs are essential to podocyte–GBM interactions	4
A new pathway links iron sensing with histone demethylation and regulation of mTORC1 activity	4
Leveraging lysine metabolism for renoprotection	4
Improving outcomes in kidney transplantation through advances in donor organ perfusion	4
Collagen IV in Gould syndrome and Alport syndrome	4
Macrophages clean out the tubules	4
From resolution to reality: advancing point-of-care diagnostics for kidney disease in low-resource settings	4
The roles of tertiary lymphoid structures in chronic diseases	4
Overcoming barriers to deliver high quality kidney care	4
Kidney benefits of SLGT2 inhibitors: evidence from clinical trials	4
Protein handling in kidney tubules	4
Cell–cell crosstalk in kidney health and disease	4
AngII autoantibodies after SARS-CoV-2 infection	4
Propagation of acute kidney injury	4
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia	4
Benefits of CoQ10 supplementation in patients with SRNS due to primary CoQ10 deficiency	4
Harnessing plant thylakoids to restore cellular function in AKI	3
Long COVID: long-term health outcomes and implications for policy and research	3
A CAAR NK cell approach to eliminate pathogenic autoantibody-secreting cells	3
Targeting perivascular S1P attenuates inflammation	3
Managing RAAS inhibitor use in advanced CKD	3
The importance of sex and gender in basic and clinical research	3
Spatial transcriptomics in health and disease	3
The global landscape of kidney registries: immense challenges and unique opportunities	3
The pathogenesis of IgA nephropathy and implications for treatment	3
Insights into basement membrane complexity	3
Reply to ‘Use of convalescent plasma in the treatment of COVID-19’	3
Bridging structure and function: artificial intelligence-based modelling of kidney proteins	3
Activation and regulation of alloreactive T cell immunity in solid organ transplantation	3
New AAV vector targets glomerular endothelial cells	3
VHL loss attracts immune cells to tumours	3
Artificial intelligence approaches to enable early detection of CKD	3